Showing 1 - 3 results of 3 for search 'P. Ljungman', query time: 0.02s Refine Results
  1. 1
    P1330: IMPACT OF COVID-19 IN HSCT ACTIVITY. A SURVEY FROM THE INFECTIOUS DISEASES WORKING PARTY (IDWP) OF EBMT

    P1330: IMPACT OF COVID-19 IN HSCT ACTIVITY. A SURVEY FROM THE INFECTIOUS DISEASES WORKING PARTY (IDWP) OF EBMT by R. De La Camara, Z. Szmit, P. Ljungman, N. Knelange, L. Wendel, G. Tridello, K. Kalwak

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)

    P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSP... by M. Wilck, O. Cornely, P. Ljungman, C. Cordonnier, J. Diego Velez, R. Dagan, P. Richmond, Q. Chen, C. Daus, K. Geddie, T. Sterling, T. Shekar, L. Musey, U. Buchwald

    Published 2022-06-01
    Get full text
    Article
  3. 3
    S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B

    S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B by M. Tobiasson, T. Pandzic, J. Illman, L. Nilsson, S. Weström, K. Sollander, E. Ejerblad, A. Olsnes Kittang, G. Olesen, O. Werlenius, A. Björklund, J. Wiggh, C. lindholm, F. Lorentz, B. Rasmussen, J. Cammenga, D. Weber, D. Grönnås, M. Dimitriou, S. Kytölä, G. Walldin, P. Ljungman, K. Groenbeck, S. Mielke, S. E. Jacobsen, F. Ebeling, L. Cavelier, L. Smidstrup Friis, I. Dybedal, E. Hellström-Lindberg

    Published 2022-06-01
    Get full text
    Article

Search Tools: